Comprehensive echocardiographic prediction of postprocedural transmitral pressure gradient following transcatheter mitral valve repair

Author(s):  
Hannes Alessandrini ◽  
Peter Wohlmuth ◽  
Felix Meincke ◽  
Samer Hakmi ◽  
Timm Ubben ◽  
...  
2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
B Koell ◽  
S Ludwig ◽  
J Weimann ◽  
L Waldschmidt ◽  
N Schofer ◽  
...  

Abstract Background A growing number of patients are currently treated for severe mitral regurgitation (MR) using a transcatheter mitral valve repair (TMVr). In clinical routine, the potential risk of elevated post-procedural mitral valve pressure gradient (MPG) may prohibit optimal MR reduction driven by the avoidance of additional clip implantations. Thus, the unfavorable impact on survival and functional outcome of increased MPG in patients undergoing TMVr is currently debatable. Methods In this single-center, prospective study, survival and functional outcome of 780 consecutive patients with severe MR undergoing TMVr between September 2008 and January 2020 were investigated. After exclusion of patients with unsuccessful procedure and those lost to follow-up, data of 676 patients with a median follow-up time of 5.26 (5.11, 5.51) years were analyzed. MPG was determined by transthoracic echocardiography at discharge and considered elevated in excess of 4.5 mmHg. Kaplan-Meier analysis as well as multivariable Cox regression models were performed for the impact on elevated MPG on 5-year outcomes for the subgroups of functional MR (FMR) and degenerative MR (DMR). The primary outcome measure was a combined endpoint of death or rehospitalization for congestive heart failure. Results Among 676 patients undergoing TMVr (mean age 74.6±8.5 years, 59.0% male, median STS Score 3.9 [interquartile range 2.5; 6.0]), 179 (26.4%) patients had elevated MPG >4.5 mmHg. FMR was present in 426 (63.0%) patients. In the overall patient cohort, Kaplan-Meier and Cox Regression analyses could not demonstrate significant differences for the combined endpoint (p=0.99). In contrast, subgroup analysis according to MR etiology indicated a significant adverse influence of elevated MPG on the combined endpoint as well as functional outcome in patients with DMR, but not with FMR (Figure 1). After adjustment, multivariate Cox Regression analysis showed an inferior prognosis in patients with DMR and elevated MVPG >4.5 mmHg (hazard ratio 1.79 [1.17, 2.72], p=0.0069, Figure 2). Conclusions TMVr-patients with DMR and measurable elevated post-procedural MVPG face an inferior prognosis and reduced functional outcomes compared to patients with FMR. FUNDunding Acknowledgement Type of funding sources: None. Figure 1 Figure 2


2021 ◽  
Vol 77 (18) ◽  
pp. 1756
Author(s):  
Michael Biersmith ◽  
Thura Harfi ◽  
David Orsinelli ◽  
Scott Lilly ◽  
Konstantinos Boudoulas

Author(s):  
Neal Duggal ◽  
Matthew Romano ◽  
Daniel Menees ◽  
Stanley J. Chetcuti ◽  
Steven F. Bolling ◽  
...  

2020 ◽  
Vol 13 (23) ◽  
pp. 2769-2778 ◽  
Author(s):  
Victor Mauri ◽  
Christian Besler ◽  
Matthias Riebisch ◽  
Osamah Al-Hammadi ◽  
Tobias Ruf ◽  
...  

Open Heart ◽  
2021 ◽  
Vol 8 (1) ◽  
pp. e001564
Author(s):  
Ole De Backer ◽  
Ivan Wong ◽  
Maurizio Taramasso ◽  
Francesco Maisano ◽  
Olaf Franzen ◽  
...  

The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.


Sign in / Sign up

Export Citation Format

Share Document